Actions

Download Analytics Citations

Export to: EndNote  |  Zotero  |  Mendeley

Collections

This file is not currently in any collections.

Developing multi-component solid formulation strategies for PROTAC dissolution enhancement [dataset] Open Access

PROTACs are an emerging class of beyond-rule-of-5 molecular drugs currently under clinical investigation for the treatment of malignant diseases and are capable of degrading previously “undruggable” protein targets. They are poorly crystallizable due to their structure, consisting of two ligands joined chemically by a flexible linker, and yet the inherent insolubility of their amorphous phases hinders their development into sufficiently bioavailable medicines. Formulation approaches to improve the dissolution properties of PROTACs are required as a result, but research in this area is made even more challenging by the scarcity of available samples. In this work, amorphous solid dispersion (ASD) formulations of four cereblon-recruiting PROTACs ‘AZ1-4’ using hydroxypropyl methylcellulose acetate succinate (HPMCAS) as a polymer excipient are described. ASDs of AZ1 showed up to a 2-fold increase in drug supersaturation compared to the pure amorphous API, observed up to a drug loading of 20 % w/w. Preparing the ASDs by slurry conversion offers greater solubility enhancement over those prepared by solvent evaporation and maintains the dissolution advantage up to a higher drug load. Positive deviations from theoretical Tg values coupled with a lack of spectral evidence of drug-polymer hydrogen-bond interactions suggest that the ASDs may differ from ideal mixtures via predominantly dispersive drug-polymer interactions. ASDs that provided a dissolution enhancement were stored at elevated temperature and humidity for one month and showed no sign of plasticization or loss of physical stability. Co-amorphous formulations using low molecular weight excipients, by contrast, showed no dissolution advantage despite evidence of drug-coformer hydrogen-bonding interactions, proving the need for a greater understanding of how to develop successful formulation approaches to bRo5 compounds.

Descriptions

Resource type

Dataset

Contributors

Creator: Steed, Jonathan ¹
Contact person: Steed, Jonathan ¹
Editor: Steed, Jonathan ¹
Data collector: Screen, Martin ¹
Editor: Screen, Martin ¹

¹ Durham University, UK

Funder

Engineering and Physical Sciences Research Council
AstraZeneca

Research methods

Other description

Keyword

Pharmaceuticals
Amorphous
PROTAC dissolution
Proteolysis Targeting Chimeras

Subject

Proteolysis
Crystallization

Location

Durham, UK

Language

English

Cited in

Identifier

ark:/32150/r15m60qr98j
doi:10.15128/r15m60qr98j

Rights

Creative Commons Attribution 4.0 International (CC BY)

Publisher

Durham University

Date Created

3/7/25

File Details

Depositor

J.W. Steed

Date Uploaded

3 July 2025, 15:07:36

Date Modified

4 July 2025, 11:07:25

Audit Status

Audits have not yet been run on this file.

Characterization

File format: zip (ZIP Format)

Mime type: application/zip

File size: 87949867

Last modified: 2025:07:03 16:06:45+01:00

Filename: Data for Developing multi-component solid formulation strategies for PROTAC dissolution enhancement.zip

Original checksum: 2360bfa206c5b5e789c4e30dbb78e900